Nuzenio

Avalo Therapeutics Reports

Avalo Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Bank of America Securities Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 10:59:00 GMTState Street Corporation (NYSE: AVTX custodian) discloses 5.5% Avalo stake - Stock TitanStock Titan · Fri, 07 Aug 2026 12:44:31 GMTAvalo Therapeutics Q2 2026 Earnings: Revenue Unreported, $36.4 Million Net Loss - Sci-Tech TodaySci-Tech Today · Fri, 07 Aug 2026 09:15:21 GMTAvalo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 15:05:51 GMTAvalo Therapeutics, Inc. 2026: Revenue ($36.94M), Net income ($36.36M), EPS ($0.83) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMTAvalo Therapeutics reports Q2 2026 net loss $36.4M; cash and investments $472.2M - TradingViewTradingView · Thu, 06 Aug 2026 11:03:01 GMTAvalo Plans 2027 Phase 3 Trial for Chronic Skin Condition - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMTAvalo Therapeutics (AVTX) CMO sells 1,000 shares after option exercise - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 10:59:00 GMTBank of America Securities Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX) - The Globe and Mail
Fri, 07 Aug 2026 12:44:31 GMTState Street Corporation (NYSE: AVTX custodian) discloses 5.5% Avalo stake - Stock Titan
Fri, 07 Aug 2026 09:15:21 GMTAvalo Therapeutics Q2 2026 Earnings: Revenue Unreported, $36.4 Million Net Loss - Sci-Tech Today
Thu, 06 Aug 2026 15:05:51 GMTAvalo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 11:11:00 GMTAvalo Therapeutics, Inc. 2026: Revenue ($36.94M), Net income ($36.36M), EPS ($0.83) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 11:03:01 GMTAvalo Therapeutics reports Q2 2026 net loss $36.4M; cash and investments $472.2M - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Avalo Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.